- Monterey County Weekly2 days ago
Classes include topics such as viral eye diseases, laser procedures for the management of glaucoma, diabetic retinopathy, cataracts and macular degeneration, among others.
Global Ophthalmology Therapeutics Market Analysis 2017 - 865 Products in Active Development - egulatory and Reimbursement Policy Shifts Favor First-in-Class...GlobeNewswire via Yahoo Finance4 days ago
The "Frontier Pharma: Ophthalmology Therapeutics - Gene Therapies and First-in-Class Targets Offer Novel Treatments for Substantial Unmet Needs in a Pipeline Dominated by Angiogenic and Immune ...
- Medscape5 days ago
Complement inhibition as a means of halting the progression of geographic atrophy took a hit this week, with negative findings announced for two pivotal phase 3 clinical trials of lampalizumab.
- Marketwired via Yahoo Finance4 days ago
The Exton, West Grove, and West Chester eye doctors at Chester County Eye Care are using this time as an opportunity to educate their patients about the relationship between diabetes and certain ...
- WebMD4 days ago
What are antioxidants? Antioxidants protect the body from damage caused by harmful molecules called free radicals. Many experts believe this damage is a factor in the development of blood vessel ...
- Abilene Reporter-News15 hours ago
Events and meetings happening in Abilene and the Big Country this week.
- Zacks via Yahoo News3 days ago
Achillion Pharmaceuticals, Inc.’s ACHN shares fell almost 7.9% in after-market trading on Tuesday, following the announcement that Johnson & Johnson’s JNJ will sell its stake in the company.
- MedicineNet.com2 days ago
They deal with death and dying every day, but many hospice care workers haven't outlined their own end-of-life wishes for medical care, researchers say.
- Thomson Reuters StreetEvents via Yahoo News5 days ago
Good day, and welcome to the Ophthotech Corporation Third Quarter 2017 Results Conference Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Kathy Galante, Vice President of Investor Relations.
NEWARK -- A hopelessly deadlocked jury brought an end to the corruption trial of U.S. Sen. Robert Menendez on Thursday, prompting the declaration of a mistrial and concluding a contentious 11 ...